IONIS PTP1BRx, with the CAS number 1403406-29-0, is an investigational therapeutic compound primarily designed for the treatment of certain diseases, including metabolic disorders. As an antisense oligonucleotide, it functions by targeting specific mRNA sequences to modulate gene expression, thereby inhibiting the production of proteins associated with disease pathology. This mechanism allows for a highly selective approach to treatment, potentially reducing side effects compared to traditional small molecule drugs. The compound's design incorporates chemical modifications that enhance its stability and binding affinity, improving its efficacy in biological systems. IONIS PTP1BRx is part of a broader class of drugs that leverage the principles of molecular biology and genetics, showcasing the innovative strategies being developed in modern pharmacotherapy. While specific pharmacokinetic and pharmacodynamic properties may vary, ongoing clinical trials are essential for determining its safety, efficacy, and potential therapeutic applications.

IONIS PTP1BRx

1403406-29-0: IONIS PTP1BRx, with the CAS number 1403406-29-0, is an investigational therapeutic compound primarily designed for the treatment of certain diseases, including metabolic disorders. As an antisense oligonucleotide, it functions by targeting specific mRNA sequences to modulate gene expression, thereby inhibiting the production of proteins associated with disease pathology. This mechanism allows for a highly selective approach to treatment, potentially reducing side effects compared to traditional small molecule drugs. The compound's design incorporates chemical modifications that enhance its stability and binding affinity, improving its efficacy in biological systems. IONIS PTP1BRx is part of a broader class of drugs that leverage the principles of molecular biology and genetics, showcasing the innovative strategies being developed in modern pharmacotherapy. While specific pharmacokinetic and pharmacodynamic properties may vary, ongoing clinical trials are essential for determining its safety, efficacy, and potential therapeutic applications.

<p>IONIS PTP1BRx (ISIS 404173) acts as an antisense inhibitor of protein tyrosine phosphatase 1B (PTP-1B). This compound exhibits anti-diabetic properties, making it suitable for research into insulin resistance related to obesity and type 2 diabetes.</p>

CAS 1403406-29-0

IONIS PTP1BRx

IONIS PTP1BRx

Ref: TM-T200394